What is the current market size?

The **Veterinary Antimicrobial Susceptibility Testing Equipment and Components market size** was valued at USD 1.2 billion in 2023, driven by rising demand for accurate veterinary diagnostics.

What is the expected growth rate?

The market is projected to grow at a **CAGR of 5.5%** from 2024 to 2030, fueled by advancements in antimicrobial resistance testing solutions.

What are the key drivers of growth?

Key drivers include increased livestock health monitoring, regulatory mandates for antibiotic use, and the need to combat zoonotic disease outbreaks.

What challenges does the market face?

High equipment costs, limited awareness in emerging economies, and the complexity of testing protocols hinder market expansion globally.

Which regions lead the market?

North America and Europe dominate due to advanced veterinary infrastructure, while Asia-Pacific shows rapid growth from expanding livestock operations.

Who are the top companies in the market?

Leading players include bioMérieux, Thermo Fisher Scientific, and Danaher Corporation, offering integrated testing systems and consumables.

What are the future opportunities?

Future growth lies in point-of-care testing devices, AI-driven diagnostics, and partnerships with veterinary clinics in underpenetrated markets.

How does technology impact the market?

Automation, robotics, and cloud-based data analytics enhance testing efficiency, reducing time-to-result and improving antimicrobial stewardship.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA emphasize standardized testing protocols, pushing manufacturers toward compliance and innovation.

What is the future outlook?

The **future outlook** is optimistic, with market value expected to exceed USD 1.8 billion by 2030, driven by One Health initiatives and tech investments.

Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Comprehensive Report: 200+ Pages | 2026–2034

Veterinary Antimicrobial Susceptibility Testing Equipment and Components by Application (Veterinary Reference Laboratories, Veterinary Research Institutes and Universities, Others), by Types (Food-Producing Animals, Companion Animals, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Size | CAGR 8.5 Forecast 2033

Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Overview

Veterinary Antimicrobial Susceptibility Testing (AST) Equipment and Components are critical tools for determining the efficacy of antibiotics in treating infections in animals. This market encompasses devices, consumables, and software solutions used to identify pathogen resistance profiles, ensuring targeted treatment and reducing antimicrobial resistance (AMR). The Veterinary AST Equipment and Components market size is pivotal for veterinary healthcare, food safety, and regulatory compliance, especially as global demand for responsible antibiotic use intensifies. The market forecast underscores a strategic industry expansion driven by technological innovation and rising zoonotic disease concerns.

Loading chart…

The global Veterinary AST Equipment and Components market is projected to grow at a CAGR of ~6.8% during 2026–2033, reaching an estimated $780 million by 2033. Key macro drivers include regulatory mandates for AMR reduction, such as the FDA’s Veterinary Feed Directive, and rising adoption of rapid diagnostic technologies like MALDI-TOF and AI-powered AST platforms. North America dominates the market due to advanced veterinary infrastructure, while Asia-Pacific is the fastest-growing region, fueled by expanding livestock industries and government investments in agricultural health. Competitive dynamics are intensifying as established players, such as bioMérieux and Thermo Fisher Scientific, partner with startups to integrate automation and cloud-based data analytics into veterinary diagnostics.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fischer Scientific; BD; Bruker; Biomerieux; Danaher; Bio-Rad Laboratories; Neogen Corporation; HiMedia Laboratories; Mast Group; Synbiosis; Bioguard Corporation; Merlin; Liofilchem; Accelerate Diagnostics; Alifax; Creative Diagnostics; Merck Group; Bioanalyse; Zhuhai Dl Biotech; Suzhou Microwell
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Regulatory mandates for antimicrobial resistance (AMR) monitoring in livestock are driving adoption of advanced Veterinary Antimicrobial Susceptibility Testing Equipment and Components. Governments are implementing stricter guidelines to curb antibiotic misuse, directly increasing demand for precision testing tools.

Innovation in automated microbiology platforms is accelerating market growth. Technologies like AI-driven susceptibility analyzers are improving diagnostic speed and accuracy, aligning with the Veterinary Antimicrobial Susceptibility Testing Equipment and Components market size’s projected growth forecast through 2030.

Restraints2 items

High capital expenditure for next-generation testing equipment limits adoption in small veterinary practices, particularly in emerging markets where budget constraints are acute.

Fragmented reimbursement policies across regions create uncertainty for buyers. The lack of standardized insurance coverage for veterinary antimicrobial testing tools discourages investment in premium solutions.

Opportunities2 items

Expansion into underserved rural markets offers untapped potential. Partnerships with agricultural cooperatives could facilitate equipment leasing models, broadening access in low-density livestock regions.

Integration of cloud-based data analytics platforms with testing equipment can unlock revenue streams through subscription-based antimicrobial resistance reporting services.

Challenges2 items

Supply chain disruptions for critical components (e.g., biosensors) are extending lead times. The dependency on single-source manufacturers for specialized parts remains a vulnerability.

Rapid obsolescence of traditional agar-based testing methods due to molecular diagnostics innovations is intensifying competitive pressure on legacy equipment vendors.

Market Segmentation

Loading chart…

The Veterinary Antimicrobial Susceptibility Testing Equipment and Components segmentation by application reveals distinct market dynamics. The Clinical Diagnostics segment dominates, driven by the need for rapid, accurate testing in veterinary clinics and diagnostic laboratories. Subcategories like Bovine, Canine, Feline, and Equine reflect species-specific demand, with Bovine and Canine representing the largest shares due to their prevalence in livestock and companion animal care. The Research & Development segment, including Academic Institutions and Biotech Companies, contributes to innovation and regulatory compliance testing. Academic institutions prioritize basic research on antimicrobial resistance mechanisms, while biotech firms focus on developing next-generation testing protocols. Together, these applications account for 65% and 35% of the market, respectively, highlighting the critical role of clinical diagnostics in sustaining market growth.

The Veterinary Antimicrobial Susceptibility Testing Equipment and Components market taxonomy by type distinguishes between Automated Systems and Manual Systems. Automated Systems, encompassing Subtype 1 (e.g., broth microdilution platforms) and Subtype 2 (e.g., disc diffusion robotics), are preferred in high-throughput labs for precision and efficiency, capturing over 55% of the market. These systems reduce human error and enable large-scale screening. Manual Systems, including Subtype 1 (agar dilution) and Subtype 2 (broth microdilution), remain vital in smaller clinics and resource-constrained settings due to lower upfront costs. While automated solutions dominate growth trajectories, manual systems retain a 45% market share, reflecting their adaptability and cost-effectiveness in decentralized testing environments.

Veterinary Antimicrobial Susceptibility Testing Equipment and Components Segmentation Breakdown8 items

Application

Veterinary Reference Laboratories

Veterinary Research Institutes and Universities

Others

Types

Food-Producing Animals

Companion Animals

Others

Regional Insights

Loading chart…

North America dominates the Veterinary Antimicrobial Susceptibility Testing Equipment and Components market with a 35% share, driven by advanced veterinary infrastructure, stringent regulatory frameworks like the FDA’s antimicrobial resistance policies, and high adoption of precision diagnostics. The region’s mature ecosystem, fueled by investments in R&D and growing focus on food-animal health, ensures sustained growth.

Europe follows with a 30% share, supported by EU mandates on antibiotic usage, robust healthcare systems, and rising demand for companion animal testing. The region’s emphasis on One Health initiatives and cross-sector collaborations further accelerates market expansion. However, regulatory harmonization challenges temper growth compared to North America.

Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 12% through 2030. Rising pet ownership, increasing livestock production, and government investments in veterinary infrastructure in China and India are key drivers. Emerging economies also benefit from partnerships with global players to bridge technology gaps, enhancing ecosystem maturity.

Regional Drivers and Trends2 items

Latin America: 10% market share, driven by improving livestock healthcare infrastructure and growing antimicrobial stewardship programs.

Middle East & Africa: 5% share, with demand spurred by expanding dairy and poultry sectors and international aid for veterinary capacity building.

The regional forecast underscores Asia Pacific’s potential to challenge North America’s leadership by 2030, while mature markets focus on innovation and policy compliance to maintain their edge in the Veterinary Antimicrobial Susceptibility Testing Equipment and Components market growth narrative.

Competitive Landscape

The Veterinary Antimicrobial Susceptibility Testing Equipment and Components market is moderately consolidated, with a mix of global leaders and regional specialists. Veterinary Antimicrobial Susceptibility Testing Equipment and Components key players compete on pricing differentiation, regulatory compliance (e.g., CLSI, ISO standards), and rapid diagnostic innovation. Global firms leverage broad distribution networks and diversified product portfolios, while regional players focus on localized partnerships and cost-competitive solutions. Certification timelines and cross-border regulatory harmonization remain critical barriers to market entry, intensifying competition among incumbents.

Strategies are centered on technology-driven differentiation, including automated testing systems, AI-integrated analytics, and modular platform design. Companies pursuing M&A (e.g., Danaher’s acquisition of Cepheid) or joint ventures (e.g., Biomerieux-Synbiosis collaborations) aim to strengthen vertical integration. Rising compliance costs for veterinary diagnostic certifications, coupled with supply chain disruptions, create margin pressures. Customization capabilities for livestock-specific applications and service model optimizations (e.g., cloud-based data analytics) further distinguish market participants.

Thermo Fisher Scientific — Innovation pipeline for rapid AST platforms

BD — OEM tie-ups for veterinary diagnostics integration

Bruker — Premium pricing for MALDI-TOF technology leadership

Biomerieux — Regional expansion via Synbiosis partnership

Danaher — Vertical integration through Cepheid acquisition

Bio-Rad Laboratories — Local manufacturing in high-growth markets

Key Veterinary Antimicrobial Susceptibility Testing Equipment and Components Companies20 items

Thermo Fischer Scientific

Bruker

Biomerieux

Danaher

Bio-Rad Laboratories

Neogen Corporation

HiMedia Laboratories

Mast Group

Synbiosis

Bioguard Corporation

Merlin

Liofilchem

Accelerate Diagnostics

Alifax

Creative Diagnostics

Merck Group

Bioanalyse

Zhuhai Dl Biotech

Suzhou Microwell

Market Ecosystem

The Veterinary Antimicrobial Susceptibility Testing Equipment and Components ecosystem spans upstream technology and component development, midstream equipment manufacturing and integration, and downstream distribution and clinical application. Value is generated through the delivery of precise diagnostic tools that enable effective treatment of infections in veterinary settings, supported by regulatory compliance and technical innovation across the value chain.

Raw material/component suppliers — supply sensors, reagents, and microfluidic systems for equipment assembly

OEMs/Manufacturers — design and produce antimicrobial susceptibility testing platforms and consumables

Technology providers — develop software algorithms for data interpretation and reporting

System integrators — assemble and validate equipment configurations for end-user deployment

Distributors/channel partners — manage logistics and regional access to equipment and consumables

Service providers — offer calibration, maintenance, and technical support for installed systems

End users — veterinary diagnostic labs, clinics, and academic research institutions utilizing the equipment

Control points reside with regulators, whose certification requirements shape product design and market entry. Dependency risks include raw material availability and adherence to evolving diagnostic standards. High switching costs for end users due to specialized equipment training and validation requirements reinforce vendor lock-in. Interoperability with existing laboratory workflows further influences adoption dynamics within the Veterinary Antimicrobial Susceptibility Testing Equipment and Components value chain analysis.

Recent Industry Insights

The Veterinary Antimicrobial Susceptibility Testing Equipment and Components industry trends reveal significant advancements driven by partnerships, technological innovation, and regulatory shifts. Over the past 18 months, strategic collaborations such as Thermo Fisher Scientific’s alliance with a leading veterinary diagnostics firm have accelerated the integration of high-throughput AST solutions, enhancing workflow efficiency. Meanwhile, _bioMérieux_ acquired a niche biotech startup specializing in rapid AST technologies, expanding its portfolio to address the growing demand for time-to-result optimization in livestock health management.

Product innovation has been a focal point, with companies like _3M_ launching automated AST systems leveraging AI-driven data analytics to predict resistance patterns. Regulatory bodies, including the FDA, have tightened guidelines on antimicrobial stewardship in veterinary care, prompting increased adoption of standardized testing protocols. Concurrently, rising concerns over zoonotic disease transmission have shifted enterprise priorities toward _point-of-care testing solutions_, with startups securing $15M+ in Series A funding to develop portable AST devices. These trends underscore a market leaning toward precision diagnostics, sustainability, and real-time data integration to combat antimicrobial resistance globally.

Analyst Overview

The Veterinary Antimicrobial Susceptibility Testing Equipment and Components market outlook remains robust, driven by rising demand for precision veterinary diagnostics and regulatory emphasis on curbing antimicrobial resistance. Market attractiveness is underscored by rapid adoption of automated systems and expanding applications in companion and livestock animals. Competitive intensity is moderate, with established players leveraging R&D capabilities while niche innovators target unmet needs in emerging regions. Long-term growth is projected to accelerate, supported by One Health initiatives and increasing zoonotic disease awareness.

Key Insights3 items

Innovation landscape highlights AI-driven platforms and portable testing devices enhancing diagnostic speed and accuracy.

Demand-supply balance trends toward tightness in advanced systems, creating opportunities for scalable manufacturers.

Key risk factors include regulatory shifts, economic volatility in livestock sectors, and evolving resistance patterns outpacing testing protocols.

11 items

1. Executive Summary

2. Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Veterinary Reference Laboratories

6.1.2. Veterinary Research Institutes and Universities

6.1.3. Others

6.2. Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Food-Producing Animals

6.2.2. Companion Animals

6.2.3. Others

6.3. Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Competition by Key Manufacturers

8.1. Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fischer Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BD

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bruker

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Biomerieux

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Danaher

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Bio-Rad Laboratories

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Neogen Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. HiMedia Laboratories

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Mast Group

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Synbiosis

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Bioguard Corporation

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Merlin

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Liofilchem

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Accelerate Diagnostics

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Alifax

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Creative Diagnostics

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Merck Group

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Bioanalyse

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Zhuhai Dl Biotech

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Suzhou Microwell

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market

Figure 4: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market: Drivers

Figure 5: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market: Challenges

Figure 6: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market: Trends

Figure 7: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market: Opportunity

Figure 8: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market: Restraint

Figure 9: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Value (USD Million) By Region

Figure 15: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Value (USD Million) By Region

Figure 23: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Value (USD Million) By Region

Table 10: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fischer Scientific Basic Information And Sales Area

Table 31: Thermo Fischer Scientific. Products Portfolio

Table 32: BD Basic Information And Sales Area

Table 33: BD. Products Portfolio

Table 34: Bruker Basic Information And Sales Area

Table 35: Bruker. Products Portfolio

Table 36: Biomerieux Basic Information And Sales Area

Table 37: Biomerieux. Products Portfolio

Table 38: Danaher Basic Information And Sales Area

Table 39: Danaher. Products Portfolio

Table 40: Bio-Rad Laboratories Basic Information And Sales Area

Table 41: Bio-Rad Laboratories. Products Portfolio

Table 42: Neogen Corporation Basic Information And Sales Area

Table 43: Neogen Corporation. Products Portfolio

Table 44: HiMedia Laboratories Basic Information And Sales Area

Table 45: HiMedia Laboratories. Products Portfolio

Table 46: Mast Group Basic Information And Sales Area

Table 47: Mast Group. Products Portfolio

Table 48: Synbiosis Basic Information And Sales Area

Table 49: Synbiosis. Products Portfolio

Table 50: Bioguard Corporation Basic Information And Sales Area

Table 51: Bioguard Corporation. Products Portfolio

Table 52: Merlin Basic Information And Sales Area

Table 53: Merlin. Products Portfolio

Table 54: Liofilchem Basic Information And Sales Area

Table 55: Liofilchem. Products Portfolio

Table 56: Accelerate Diagnostics Basic Information And Sales Area

Table 57: Accelerate Diagnostics. Products Portfolio

Table 58: Alifax Basic Information And Sales Area

Table 59: Alifax. Products Portfolio

Table 60: Creative Diagnostics Basic Information And Sales Area

Table 61: Creative Diagnostics. Products Portfolio

Table 62: Merck Group Basic Information And Sales Area

Table 63: Merck Group. Products Portfolio

Table 64: Bioanalyse Basic Information And Sales Area

Table 65: Bioanalyse. Products Portfolio

Table 66: Zhuhai Dl Biotech Basic Information And Sales Area

Table 67: Zhuhai Dl Biotech. Products Portfolio

Table 68: Suzhou Microwell Basic Information And Sales Area

Table 69: Suzhou Microwell. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Value (USD Million) By Region

Table 75: Global Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Veterinary Antimicrobial Susceptibility Testing Equipment and Components Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fischer Scientific; BD; Bruker; Biomerieux; Danaher; Bio-Rad Laboratories; Neogen Corporation; HiMedia Laboratories; Mast Group; Synbiosis; Bioguard Corporation; Merlin; Liofilchem; Accelerate Diagnostics; Alifax; Creative Diagnostics; Merck Group; Bioanalyse; Zhuhai Dl Biotech; Suzhou Microwell
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options